Aspiro Pharma Limited has recalled certain lots of Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), a prescription medication used for pain management. The recall was initiated because the vials may contain particulate matter identified as glass. Using an injectable medication contaminated with glass particles can lead to serious health complications, including local irritation, inflammation, or more severe systemic issues if the particles travel through the bloodstream.
The presence of glass particles in an injectable drug poses a risk of vascular irritation, inflammation, or the formation of granulomas. In severe cases, these particles could cause blockages in vital organs or systemic adverse reactions.
Manufactured for Camber Pharmaceuticals, Inc. by Aspiro Pharma Limited.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.